Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals

Topic: Plasma and spinal-fluid biomarkers

See Vandenberghe and Schaeverbeke (doi:10.1093/awx065) for a scientific commentary on this article. A long-term goal of our field is to determine the sequence of pathological events, which ultimately lead to cognitive decline and dementia. In this study, we first assessed the patterns of brain tau tangle accumulation (measured with the positron emission tomography tracer 18F-AV-1451) associated with well-established Alzheimer's disease factors in a cohort including cognitively healthy elderly individuals and individuals at early symptomatic stages of Alzheimer's disease. We then explored highly associated patterns of greater 18F-AV-1451 binding and increased annualized change in cortical amyloid-β plaques measured as florbetapir positron emission tomography binding antecedent to 18F-AV-1451 positron emission tomography scans, and to what extent these multimodal pattern associations explained the variance in cognitive performance and clinical outcome measures, independently and jointly. We found that: (i) 18F-AV-1451 positron emission tomography retention was differentially associated with age, and cross-sectional florbetapir positron emission tomography retention, but not with years of education, gender, or APOE genotype; (ii) increased annualized change in florbetapir retention, antecedent to 18F-AV-1451 positron emission tomography scans, in the parieto-temporal and precuneus brain regions was associated with greater 18F-AV-1451 PET retention most prominently in the inferior temporal and inferior parietal regions in the full cohort, with florbetapir positive/negative-associated variability; and (iii) this 18F-AV-1451 positron emission tomography retention pattern significantly explained the variance in cognitive performance and clinical outcome measures, independent of the associated antecedent increased annualized change in florbetapir positron emission tomography retention. These findings are in agreement with the pathology literature, which suggests that tau tangles but not amyloid-β plaques correlate with cognition and clinical symptoms. Furthermore, non-local associations linking increased amyloid-β accumulation rates with increased tau deposition are of great interest and support the idea that the amyloid-β pathology might have remote effects in disease pathology spread potentially via the brain's intrinsic connectivity networks.

Key findings

• In this study, we first assessed the patterns of brain tau tangle accumulation (measured with the positron emission tomography tracer 18F-AV-1451) associated with well-established Alzheimer's disease factors in a cohort including cognitively healthy elderly individuals and individuals at early symptomatic stages of Alzheimer's disease.
• We found that: (i) 18F-AV-1451 positron emission tomography retention was differentially associated with age, and cross-sectional florbetapir positron emission tomography retention, but not with years of education, gender, or APOE genotype; (ii) increased annualized change in florbetapir retention, antecedent to 18F-AV-1451 positron emission tomography scans, in the parieto-temporal and precuneus brain regions was associated with greater 18F-AV-1451 PET retention most prominently in the inferior temporal and inferior parietal regions in the full cohort, with florbetapir positive/negative-associated variability; and (iii) this 18F-AV-1451 positron emission tomography retention pattern significantly explained the variance in cognitive performance and clinical outcome measures, independent of the associated antecedent increased annualized change in florbetapir positron emission tomography retention.
• These findings are in agreement with the pathology literature, which suggests that tau tangles but not amyloid-β plaques correlate with cognition and clinical symptoms.

New to this subject? Start with our plain-English guide: Brain scans & tests →

Study details

• Study designcross-sectional
• Evidence strengthModerate

Read the original

• DOI: 10.1093/brain/awx046
• PubMed: 28334939
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{tosun2017-28334939,
  author  = {Tosun, Duygu and Landau, Susan M. and Aisen, Paul S. S and Petersen, Ronald Carl and Mintun, Mark A. and Jagust, William and Weiner, Michael Walter and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals}},
  journal = {Brain},
  year    = {2017},
  doi     = {10.1093/brain/awx046},
  pmid    = {28334939},
  url     = {https://doi.org/10.1093/brain/awx046}
}

Related studies in Brain scans and imaging

• Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease Journal of Alzheimer's disease : JAD · 2018-01-01 · usefulness score 38/100
• Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease EMBO molecular medicine · 2009-11-01 · usefulness score 40/100
• Regional Amyloid Accumulation and White Matter Integrity in Cognitively Normal Individuals Journal of Alzheimer's disease : JAD · 2020 · usefulness score 43/100
• Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals Archives of neurology · 2012-02-01 · usefulness score 52/100
• Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease JAMA neurology · 2018-05-01 · usefulness score 60/100
• Longitudinal tau‐PET accumulation and downstream effects in amyloid‐beta negative cognitively unimpaired individuals Alzheimer s & Dementia · 2025-12-01 · usefulness score 46/100

Similar studies

• Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease 2017 · Brain scans and imaging
• Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition 2017 · Brain scans and imaging
• Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study 2022 · Brain scans and imaging
• Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease 2026 · Brain scans and imaging
• The impact of amyloid-beta and tau on prospective cognitive decline in older individuals 2019 · Brain scans and imaging
• Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex 2025 · Brain scans and imaging

More on Brain scans and imaging

• A review that covers this ground Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review Movement disorders : official journal of the Movement Disorder Society · 2015-04-16 · usefulness score 64/100
• Newest in this subject Large-scale head-to-head comparison of on- and off-target profiles of [18F]Tauvid and [18F]MK6240 tau-PET in aging and Alzheimer’s disease Research Square · 2026-11-01 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Repetitive negative thinking is associated with amyloid accumulation over 3 years in cognitively healthy adults medRxiv · 2026-10-31 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Brain scans and imaging →